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Host factors belonging to the DNA repair machineries are assumed to aid retroviruses in the obligatory step of
integration. Here we describe the effect of DNA repair molecule Rad18, a component of the post-replication repair
pathway, on viral infection. Contrary to our expectations, cells lacking Rad18 were consistently more permissive to
viral transduction as compared to Rad18
þ/þ controls. Remarkably, such susceptibility was integration independent,
since retroviruses devoid of integration activity also showed enhancement of the initial steps of infection. Moreover,
the elevated sensitivity of the Rad18
 /  cells was also observed with adenovirus. These data indicate that Rad18
suppresses viral infection in a non-specific fashion, probably by targeting incoming DNA. Furthermore, considering
data published recently, it appears that the interactions between DNA repair components with incoming viruses, often
result in inhibition of the infection rather than cooperation toward its establishment.
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Introduction
The life cycle of retroviruses distinguishes itself from that
of other viruses by the fact that it undergoes a process of
reverse transcription and insertion of its genome into that of
the host. This latest step is carried out by viral integrase (IN)
in concert with host proteins most likely to be part of the
various DNA repair machineries. A number of physical and/
or functional interactions have been described between the
viral constituents involved with the integration process and
cellular elements that may act as cofactors for catalysis or gap
repair, reviewed by Turlure et al. [1]. Mechanisms that have
been proposed to be involved in DNA repair and DNA
metabolism during retroviral integration include: base
excision repair [2,3], homologous recombination (HR) [4]
and non-homologous end joining [5–8]. Furthermore Lau et
al. [9] have recently reported that the HR molecule Rad52 is a
suppressor of HIV-1 infection, but ruled out a direct role of
HR, as other proteins of this pathway did not affect retroviral
transduction.
We have previously described that Rad18, a molecule
belonging to a distinct DNA repair pathway known as post-
replication DNA repair, associates with HIV-1 integrase when
both proteins are overexpressed in human embryonic kidney
(HEK) 293T cells [10]. Under these conditions, such associ-
ation results in the stabilization of integrase, a substrate of
the proteasome N-end rule pathway [11,12], as well as the co-
localization of IN and Rad18 in nuclear structures.
Studies on the mechanism of post-replication DNA repair,
both in yeast and mammalian cells, have shown that Rad18 is
directly responsible for the speciﬁc mono-ubiquitylation of
the polymerase adapter PCNA [13–16]. These reports show
strong evidence of the preferential binding of polymerase g
to mono-ubiquitylated PCNA, and that such binding takes
place in replication foci in a Rad18-dependent fashion
[15,16]. The absence of Rad18 in yeast has also been identiﬁed
as the cause of gross chromosomal rearrangements [17],
whereas in chicken and in mouse cells, Rad18 deﬁciency
results in genome instability, speciﬁcally in an increase of
sister chromatid exchange [18,19]
Here we present the results of a genetic study on the
relevance of Rad18 in the early phases of viral infection. We
show that Rad18 suppresses viral infection. Moreover, we
determined that Rad18 inhibitory activity is not restricted
to retroviruses, but extends to adenovirus as well. Further-
more, we provide evidence that suggests that Rad18 acts on
the viral DNA, preventing it from reaching the replicative
stage.
Results
Rad18 Influences the Susceptibility to Retroviral Infection
Because we previously found that Rad18 interacts with
HIV-1 IN [10], we set out to investigate the susceptibility of
cells devoid of Rad18 to HIV-1 infection. RAD18
 /  primary
murine embryonic ﬁbroblasts (MEFs) [16] and their wild-type
counterpart were inoculated with increasing amounts of a
vesicular stomatitis virus protein G (VSV-G) pseudotyped
HIV-1–based enhanced green ﬂuorescent protein (EGFP)
reporter virus [20]. Analysis by ﬂow cytometry for EGFP
expression showed, surprisingly, that the Rad18
 /  cells were
approximately5-foldmoresensitivetoinfectionthanRad18
þ/þ
cells (t test p-value¼0.007) (Figure 1A).
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infection of the Rad18
 /  cells was speciﬁc to HIV-1, we
infected Rad18
 /  and Rad18
þ/þ cells with murine leukemia
virus (MLV). Cells were inoculated with increasing amounts of
an ecotropic envelope pseudotyped MLV-based retroviral
vector expressing EGFP as reporter. Figure 1B shows that
cells lacking Rad18 displayed approximately a 6-fold higher
rate of infection as compared to Rad18
þ/þcells (t test p-value¼
7.795E 06).
Because we failed to obtain stable Rad18
 /  MEF cell lines
complemented with Rad18, most likely due to the toxicity of
Rad18 long-term unregulated expression, we next tested
whether transient expression of Rad18 in human cells would
inhibit infection. Hela were cells transfected with a bicistronic
vector encoding Rad18-IRES-HcRed or as a control IRES-
HcRed only, and infected with HIV-1–based EGFP reporter
virus. Figure 1C shows that Rad18 overexpressing cells are
markedly more resistant to HIV-1 infection (t test p-value ¼
0.017) as compared to cells transfected with control plasmid.
Taken together, these results indicate that Rad18 has an
inhibitory effect on retroviral infection.
The Increase in Infection of Rad18
 /  Cells Is Independent
of Integrase Activity and Is Not Dependent on Illegitimate
Integration
Rad18
 /  cells have a high frequency of sister chromatid
exchange, and more efﬁciently incorporate selectable
markers by stable transfection [19]. Given our previous
ﬁndings, we asked if the increased susceptibility to infection
in these cells was integrase dependent or if a higher
integration frequency could occur in the Rad18
 /  cells even
in the absence of a catalytically active viral integrase,
facilitated by the absence of a functional post-replication
DNA repair pathway. To test this assumption, cells were
inoculated with HIV-1–based VSV-G pseudotyped reporter
viruses with integrase harboring a mutation in the catalytic
domain at the position D116 [21]. Figure 2 shows that the
proportion of EGFP-positive cells was indeed 4-fold (t test p-
value ¼ 0.00042) higher in Rad18 knockout cells than in
RAD18
þ/þ, suggesting that the increase in infection of Rad18
 / 
cells is independent of integrase catalytic activity.
In order to assess whether the EGFP expressed in cells
infected with a mutant virus originated from integrase-
independent integrated provirus or from non-integrated
episomal viral DNA, Rad18
þ/þ and Rad18
 /  cells were
Figure 1. Rad18 Influences the Susceptibility to Retroviral Infection
(A) Rad18
 /  MEFs, demonstrate a greater sensitivity to an HIV-1–based
EGFP reporter virus infection as compared to wild type. Cells were infected
with serial dilutions of an HIV-1–based EGFP reporter virus and assessed
after 40–44 h by flow cytometry. Virus titers (IU) were measured in NIH3T3
cyc.T cells.
(B) Rad18
 /  MEFs demonstrate a greater sensitivity to infection with MLV
vector–derived virus as compared to wild type. MLV-based EGFP reporter
virus was used to infect cells that were then assessed by flow cytometry
40–44 h later.
(C) Hela cells expressing human Rad18 are more resistant to HIV-1 infection
as compared to cells transfected with control plasmid. Cells transiently
transfected with either hRad18-IRES-HcRed vector or IRES-HcRed control
vector were infected with serial dilutions of a HIV-1–based EGFP reporter
virus and assessed after 40–44 h by flow cytometry.
DOI: 10.1371/journal.ppat.0020040.g001
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Rad18 in Viral Infection
Synopsis
Various cellular factors are thought to interact with invading
retroviruses, either assisting the viral proteins or functioning as
protecting factors against them. Productive viral infection, therefore,
depends on the way the equilibrium between these two opposite
group of molecules is leaning. The authors find that Rad18, a
component of the post-replication DNA repair pathway, instead of
aiding retroviral infection suppresses its establishment, interfering
with the accumulation of the invading DNA. They also find that such
suppressive activity is not restricted only to retroviruses but also
concerns adenovirus infection. These results, in conjunction with
those recently published, lead the authors to hypothesize a role for
DNA repair mediated genome stability maintenance in viral
infection, or in other words, that viral invasion is also a matter of
genome stability.inoculated with a HIV-1 retroviral vector–derived virus
harboring a catalytically inactive integrase and split 1:10 at
day 2, 5, and 9 post-infection. At the same time points,
aliquots of the infected cells were analyzed by ﬂow cytometry
for EGFP expression. Figure 2B shows the frequency of EGFP-
positive cells over time in RAD18
þ/þ and in Rad18
 /  cells.
Rad18
þ/þ EGFP-positive cells are barely detectable, whereas
Rad18
 / cells show a higher frequency of positive cells, with a
steady time-dependent decline. These results show that EGFP
expression from IN-defective virus originates from non-
integrated viral cDNA that may accumulate in greater
quantities in Rad18
 /  than in Rad18
þ/þ and is then lost by
dilution during cell division.
In parallel, we infected Rad18
þ/þ and Rad18
 /  cells with
saturating amounts (about 250,000 infectious units [IU]) of
HIV-1–derived retroviral vector–carrying wild-type integrase
to test whether the absence of Rad18 could cause upon
infection premature death as the result of the failure to
repair the integration site. Cells were split and analyzed 2, 5,
and 9 days post-infection. Figure 2C shows that, over time,
the rate of infected cells does not change, both for the
Rad18
þ/þ cells and for the Rad18
 /  cells, indicating that
Rad18 is dispensable for stable retroviral integration and that
infection is not cause of widespread cell death, as conﬁrmed
by microscopy inspection (unpublished data).
Rad18 Affects the Accumulation of Retroviral DNA
To test the presence of an increased accumulation of viral
cDNA in Rad18
 /  cells, we measured the levels of late reverse
transcription products. Cells transduced with VSV-G pseu-
dotyped integration-deﬁcient HIV-1 retrovirus were har-
vested at different time points and late reverse transcription
was estimated by quantitative PCR (QPCR). Figure 3A shows
that cDNA peaks between 8 and 12 h post-infection and that
Rad18-negative ﬁbroblasts accumulate 2- to 5-fold more viral
cDNA at 12 and 24 h than Rad18
þ/þ cells (t test p-value ¼ 0.05
and 0.013, respectively).
In order to measure the levels of viral cDNA synthesis in
the presence of overexpressed Rad18, Hela cells transfected
with Rad18-IRES HcRed-expressing plasmid or HcRed con-
trol were infected with VSV-G pseudotyped integration-
deﬁcient HIV-1 retrovirus and sorted at 12 and 20 h post-
infection. Figure 3B shows that Rad18-expressing Hela cells
accumulate 2.2- to 3-fold more cDNA as compared to control
cells (t test p-value ¼ 0.02 and 0.014, respectively). This result
is seemingly at odds with that observed with the Rad18
 / 
MEFs in which the absence of Rad18 increased the accumu-
lation of viral cDNA. However overexpression of Rad18 likely
results in the titration of other components of Rad18-
containing complexes, including those that inﬂuence retro-
viral cDNA metabolism. The saturation of these degradation
complexes may preclude their contact with the incoming
viral DNA and thereby result in the observed increased
reverse transcription product accumulation. Nonetheless,
both under- or overexpression of Rad18 affect both reverse
transcription and infection, and those ﬁndings suggest that
Rad18 modulates either the reverse transcription reaction or
the stability of the reverse transcription product.
Increased Adenovirus Infection in Rad18-Negative Cells
Because the effect of Rad18 on retroviral infection seemed
to involve viral cDNA accumulation, we next asked whether
Figure 2. The Increase in Infection of Rad18
 /  Cells Is Independent of
Integrase Activity and Is Not Dependent on Illegitimate Integration
(A) Rad18
 /  MEFs show a greater susceptibility to infection with an
integration-inert HIV-1 virus as compared to Rad18
þ/þ cells. Cells were
infected with an integration-deficient HIV-1–based EGFP reporter virus
using serial dilutions of p24 values equivalent to 125,000 IU of wild-type
virus and then assessed after 40–44 h by flow cytometry.
(B) MEFs Rad18
 /  and Rad18
þ/þ infected with an integration-deficient
HIV-1–based EGFP reporter virus were assessed by flow cytometry at 2, 5,
and 9 d after infection.
(C) MEFs Rad18
 / and Rad18
þ/þinfected with HIV-1–based EGFP reporter
virus and assessed by flow cytometry at 2, 5, and 9 d after infection.
DOI: 10.1371/journal.ppat.0020040.g002
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Rad18 in Viral Infectionthis was due to an effect on reverse transcription or,
alternatively, on the degradation of its product. To address
this question, we infected both RAD18
þ/þ and Rad18
 /  cells
with a recombinant replication-defective adenovirus express-
ing EGFP as reporter. As can be seen in Figure 4, Rad18
 / cells
are 4- to 5-fold more sensitive to adenovirus infection than
Rad18
þ/þcontrols (t test p-value¼0.02 and 0.019, respectively).
Since adenoviruses replicate independently of reverse tran-
scription and integration, this ﬁnding suggests that the Rad18
effect on both adeno- and retro-virus infections is the
consequence of a response to the presence of foreign DNA
rather than the inhibition of reverse transcription.
Discussion
Prompted by the interaction of the HIV-1 integrase with
DNA repair molecule Rad18 [10], we set out to study the
effect of Rad18 on retroviral infection.
Surprisingly, cells that lack Rad18 were consistently more
susceptible to viral infection than their Rad18
þ/þ controls.
Moreover,Rad18-negativecellswerenotonlymoresensitiveto
HIV-1, but also to MLV and adenovirus. Notably, the increase
of infection efﬁciency of the Rad18
 /  cells is integration
independent, as the effect also occurs using HIV-1 lacking
functional integrase. The absence of strongspeciﬁcity suggests
thattheapparentanti-viralactivityofRad18targetsacommon
component in the early phases of infection of all three types of
viruses, probably double-stranded DNA. This notion is
consistent with the ﬁnding that the abundance of viral cDNA
product was higher in the Rad18
 / cells. The observation that
differencesintheaccumulationofcDNAbecomeevidentafter
the eighth hour post-infection suggests that Rad18 inhibitory
effect may be detectable only when the reverse transcription
product has crossed the nuclear envelope and can therefore
come in contact with this nuclear protein. Furthermore, this
could also explain some of the earlier phenotypes observed in
the original RAD18
 / embryonic stem cells [19]. In these cells,
asubstantialincreaseinthenumberofstabletransfectantswas
observed, an outcome that could reﬂect an altered fate of the
incoming DNA
ThefactthataDNArepairproteinsuchasRad18suppresses
retroviral infection instead of aiding its establishment is only
partially counterintuitive. Indeed, studies in yeast have
reported that a number of molecules involved in DNA repair
and genome stability have an inhibitory effect on retrotrans-
position [22,23]. Furthermore, studies in mammalian cells
suggest a protective role for DNA repair molecules against
viruses. Rad52, a constituent of the HR system important in
the repair of double-strand breaks, has recently been reported
to suppress HIV-1 infection [9], as have nucleotide excision
repair helicases XPB and XPD [24]. Additionally, the antiviral
activity of APOBEC3G [25] is thought to involve a rapid
degradation of reverse transcribed viral cDNA [26], and this is
proposed to be the result of the sequential activity of enzymes
such as UNG2 and APE1, both components of the base
excision repair DNA repair pathway. Finally, formation of
retroviral DNA circles, promoted by components of the non-
homologous end joining for the two–long terminal repeat
(2LTR) circles [8], and the HR Mre11 for the one–long
terminal repeat (1LTR) circles [4], could be considered the
result of an anti-viral activity by these two DNA repair
pathways, rather than merely infection byproducts.
Figure 3. Rad18 Affects the Accumulation of Retroviral DNA
(A) MEFs Rad18
 / infected with HIV-1–based EGFP reporter virus present
a higher amount of reverse transcription product as compared to wild-
type cells. Cells were infected with 12,500 IU of a VSV-G pseudotyped
HIV-1 integration-deficient reporter virus for 4 h, and late reverse
transcripts were assessed by QPCR at 4, 8, 12, and 24 h after infection.
(B) Hela cells transfected with Rad18-IRES-HcRed and IRES-HcRed control
plasmids were infected with 12,500 IU of a VSV-G pseudotyped HIV-1
integration-deficient reporter virus. HcRed-positive cells were then
sorted 12 and 20 h post-infection, and late reverse transcripts were
assessed by QPCR.
DOI: 10.1371/journal.ppat.0020040.g003
Figure 4. Increased Adenovirus Infection in Rad18-Negative Cells
Rad18
 / MEFs show a greater susceptibility to infection with adenovirus
expressing EGFP as a reporter as compared to wild type. Cells were
infected with serial dilutions of adenovirus EGFP and assessed by flow
cytometry 40–44 h after infection. Virus titers (IU) were measured in MEFs
Rad18
 / .
DOI: 10.1371/journal.ppat.0020040.g004
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Rad18 in Viral InfectionIn principle, one might therefore consider DNA repair
molecules as components of a broader intrinsic immunity to
viruses [27]. Within the preintegration phase of retroviral
infection, for example, several steps are potential targets for
intracellular immunity. The APOBEC3G system targets the
nascent retroviral cDNA; Rad52, XPB, XPD, and Rad18 may
target the linear cDNA, potentially mediating its degradation;
andﬁnally,non-homologousendjoiningandMre11inducethe
circularization of the remaining viral genome, preventing it
from being a substrate for integration. Many of the mecha-
nisms involved are still unclear, but the emerging picture is
that the maintenance of genome integrity by DNA repair
systems has signiﬁcant consequences for viral parasitism.
Materials and Methods
Cells and cell lines. Rad18
 /  and Rad18
þ/þ MEFs established from
Rad18
 /  knockout and Rad18
þ/þ mice were described earlier [16].
MEFs, Hela, and HEK 293T cells were cultured in DMEM 10% FCS.
Viral vectors, expression plasmids, and virus production. Retro-
viruses were produced by three plasmid transfection of either HIV-1
or MLV EGFP-bearing vectors in conjunction with Gag-Pol–express-
ing plasmids and a third plasmid encoding the appropriate envelope
protein. HIV-1 reporter vector pHR SIN CSGW was described earlier
[20]. HIV-1 Gag-Pol polyprotein was expressed from expression
vector pNL/R7 g-p. MLV reporter vector was constructed by cloning
EGFP cDNA into the pLNCX2 (Clontech, Palo Alto, California,
United States) vector. VSV-G was expressed from plasmid phCMV G
[28]. MLV Gag-Pol polyprotein, expressed from plasmid phCMV-
intron Gag-Pol, is a gift from Franc ¸ois-Loic Cosset (LVRTG, ENS de
Lyon–U412 INSERM, Lyon, France). Plasmid FB MO SALF encoding
the MLV ecotropic envelope was described before [29].
HEK 293T cells were transfected using Lipofectamine 2000
(Invitrogen) or polyethylenimine (PEI) (Polysciences, Warrington,
Pennsylvania, United States) [30]. About 40 h after transfection,
supernatants were harvested; 0.45 lm was ﬁltered, aliquoted, and
frozen at 70 8C. Retroviruses were titrated for infectivity in NIH3T3
CycT [31]. HIV-1 was also quantitated by p24 enzyme-linked
immunosorbent assay (ELISA) performed using the HIV-1 p24
Antigen EIA kit (Beckman Coulter, Allendale, New Jersey, United
States).
Adenovirus reporter vector pAdenoVatorDE1/E3 CMV-5 EGFP,
containing the genome of adenovirus serotype 5 (Ad5) with deleted
E1 and E3, was constructed by cloning EGFP cDNA into pAdenoVa-
tor-CMV-5 (Qbiogene, Irvine, California, United States) and then
inserting the adenovirus CMV-5 EGFP containing region of the
construct into pAdenoVatorDE1/E3 by homologous recombination
through transformation of Escherichia coli strain BJ5153 as recom-
mended by the manufacturer.
EGFP reporter adenovirus was produced by transfection of
pAdenoVatorDE1/E3 CMV-5 EGFP and serial ampliﬁcation in HEK
293A (Qbiogene) following the manufacturer’s recommendations.
The bicistronic Rad18 vector consists of the human version of an
N-terminal FLAG-tagged Rad18 followed by an EMCV IRES and
HcRed sequence as reporter.
Infections and ﬂow cytometry analysis. Rad18
 /  and Rad18
þ/þ
MEFs were plated in 24-well plates at 40,000 cells/well, and infected
with serial dilutions of the various viruses. Infections were carried out
overnight and, in the case of the retroviruses, in the presence of 8 lg/
ml of polybrene. About 44 h after infection, cells were trypsinized,
ﬁxed with PBS 3% formaldehyde (Tousimis, Rockville, Maryland,
United States), and analyzed for EGFP expression by ﬂow cytometry
using FACScalibour instrument (Becton Dickinson, Palo Alto,
California, United States); 20,000 events were acquired per sample.
For transfection/infection experiments, Hela cells were transfected
with plasmids encoding Rad18-IRES-HcRed or IRES-HcRed only, as
control, using Lipofectamine 2000 (Invitrogen, Carlsbad, California,
United States). Twenty-four hours after transfection, cells were
infected with serial dilutions of HIV-1–derived EGFP reporter virus.
After 48 h, cells were analyzed by ﬂow cytometry and infection was
determined as the percentage of HcRed-positive cells expressing the
viral-derived EGFP reporter molecule.
Quantitative PCR. Rad18
 /  and Rad18
þ/þ MEFs were plated in 24-
well plates at a density of 40,000 cells/well. The following day, cells
were infected with VSV-G pseudotyped HIV-1 integration-deﬁcient
reporter virus previously treated with 150 units/ml of DNase I (Roche,
Indianapolis, Indiana, United States) for 30 min at 37 8C. Infections
were carried out for 4 h in the presence of 8 lg/ml of polybrene, then
cells were rinsed with PBS and fed with complete medium. Cells were
harvested at time points 4-, 8-, 12-, and 24-h post-infection, pelleted,
and frozen at  70 8C. In the case of the transfection/infection
experiments, Rad18-IRES-HcRed and IRES-HcRed control trans-
fected cells were infected with DNase I–treated VSV-G pseudotyped
HIV-1 integration-deﬁcient reporter virus. Twelve and twenty hours
post-infection, HcRed-positive cells were sorted with MoFlo cell
sorter (Cytomation, Fort Collins, Colorado, United States), pelleted,
and frozen at  70 8C. Total genomic DNA was extracted using
QIAamp DNA Blood kit (Qiagen, Valencia, California, United States)
and eluted in 100-ll ﬁnal volume; 2 ll of each sample were used in
order to perform QPCR. Primers used for the detection of late
reverse transcription products were the following: primer 1002 91–
119 TCTCTGGCTAACTAGGGAAC and 950 339–320
GCCGCCCCTCGCCTCTTG. Reporter ﬂuorophore for the labeling
of double-stranded DNA product was SYBR green (Molecular Probes,
Eugene, Oregon, United States) and reactions and acquisitions were
performed using ABI PRISM 7700 Sequence Detector (Applied
Biosystems, Foster City, California, United States) and 7500 Real
Time PCR System (Applied Biosystems). Normalization was accom-
plished by measuring the DNA concentration of each sample using
PicoGreen dsDNA Quantitation Reagent (Molecular Probes) follow-
ing manufacturers instructions. Data are presented as number of late
reverse transcription molecules per nanogram of total genomic DNA.
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